IL‐17 blocking antibody has been shown to be effective for spondyloarthropathy and psoriatic arthritis, chronic inflammatory diseases with excessive bone formation, indicating a positive effect of IL‐17 on bone formation.27, 28. The gene discussed is IL17A; the disease is spondyloarthropathy.